Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 6/20 | 0.60 |
| ▸ | HTT | P42858 | 5/20 | 0.60 |
| ▸ | LMNA | P02545 | 4/20 | 0.60 |
| ▸ | MEN1 | O00255 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | ESR1 | P03372 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7912157 | 0.85 | LMNA (0.55) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7912155 | 0.84 | NPSR1 (0.56) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7914884 | 0.83 | ALDH1A1 (0.66) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7914894 | 0.79 | NPSR1 (0.57) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7918577 | 0.79 | NPSR1 (0.61) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL27965124 | 0.78 | KMT2A (0.79) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7913323 | 0.78 | KMT2A (0.73) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7904990 | 0.77 | NPSR1 (0.55) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL27956430 | 0.76 | ALDH1A1 (0.69) | NPSR1HTTLMNAMEN1KMT2A | |
| SCHEMBL7915167 | 0.75 | HTT (0.73) | NPSR1HTTLMNAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6207666-B1 | TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE | CELL PATHWAYS, INC. | 2001-03-27 | — | — | US | disclosed |